President Donald J. Trump has signed a Presidential Memorandum aimed at increasing transparency and accuracy in direct-to-consumer prescription drug advertisements. The action is intended to ensure that Americans receive complete and accurate information when viewing advertisements for prescription medications.
"President Trump is taking action to protect patients from the negative effects of direct-to-consumer prescription drug advertising."
The administration states that this move fulfills a commitment to prioritize Americans' interests and promote greater transparency in healthcare communications.
"President Trump is delivering on his promise to put Americans first and bring radical transparency to the American people."
The memorandum seeks to address concerns about potentially misleading information in drug advertisements, with the goal of protecting patients and improving public understanding of prescription drugs.
